A new market study, titled “Blood Screening Market Forecast 2021-2028” has been featured on Fortune Business Insights™.
***Get Latest Updated Market Research Report with Free Sample Report
The global blood screening market size is projected to reach USD 4.09 billion by the end of 2026. The increasing awareness regarding blood disorders will lead to a wider adoption across the world. According to a report published by Fortune Business Insights, titled “Blood Screening Market Size, Share & Industry Analysis, By Product Type (Instruments, and Reagents & Kits), By Technology (Molecular Tests, and Serology Tests), By End User (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 2.31 billion in 2018 and will exhibit a CAGR of 7.4% during the forecast period, 2019-2026.
Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-screening-market-102552
Blood screening is a process that is carried out before blood donations or transfusions. It is carried out to examine and study the nature of the blood and detect infectious presence. Contributions from government as well as private organizations towards the use of blood screening processes will emerge in favour of the companies operating in this market. The increasing number of regulatory approvals for new tests will bode well for the market in the coming years. Moreover, the increasing investment towards developing advanced processes will have a positive impact on the growth of the market in the foreseeable future.
Increasing Number of Regulatory Approvals Will Aid Market Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. The increasing number of regulatory approvals has had a massive impact on the growth of the market in recent years. The high investments made by large scale companies have yielded improved products; subsequently leading to an increasing number of FDA cleared products. Grifol’s latest approval for its Procleix Ultrio Elite and Procleix WNV is a perfect example of a major industry development of recent times. Grifol’s latest approval will come as a welcome step towards the growth of the company. Moreover, this step will have a direct impact on the global market, considering the worldwide consumer base coverage of the company.
North America to Emerge Dominant; Increasing Investments by Major Companies Will Aid Market Growth
The report analyses the ongoing blood screening market trends across North America, Latin America, Asia Pacific, and the Middle East and Africa. Among these regions, the market in North America currently dominates the global market accounting to the massive adoption of blood screening procedures by people across the country. The increasing awareness regarding the adverse effects of use of contaminated blood has played a major part towards the rapid adoption of this procedure. As of 2018, the market in North America was worth USD 967.0 million and this value is projected to increase further in the coming years.
Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/blood-screening-market-102552
A few of the leading companies that are operating in the global blood screening market include:
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche
- Ortho Clinical Diagnostics
- DiaSorin S.p.A.
- Thermo Fisher Scientific Inc.
- Other Players
April 2019: Bio-Rad Laboratories, Inc. announced that it has received approval from the U.S Food Drug and Administration (FDA) for its IH-500 system.
NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245